← Leaderboards
Krishnamurti Lakshmanan
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$356,062
Attributed
$356,062
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $134.2K · FY2009–11$200K$150K$100K$50K$0
'09
'10
'11
Funding mix
By agency
NIH$356,062 · 1
By mechanism
N01$356,062 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Pittsburgh/Upmc Hlth Sys
Same institution · by research overlap
- Ellen R. Wald$8,036,977
- Lakshmanan Krishnamurti$5,191,890
- Silva A Arslanian$10,512,392
- Alejandro Hoberman$8,636,174
- Dorothy J Becker$40,929,090
Others in their field
Top investigators on “Award”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Christopher McKay · Battelle Memorial Institute$290,340,771
- Everette D Joseph · Howard University$268,880,223
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$257,600,678
- Eric J Barron · Pennsylvania State Univ University Park$257,427,799
Research focus
AwardChronicClinical Research SiteClinical Trials DesignContractorControlled Clinical TrialsData Coordinating CenterDouble-Blind MethodEchocardiographyEnrollmentExerciseHypertensionPharmacy DistributionsPhase Ii/Iii TrialPlacebo ControlPressurePulmonary Artery StructurePulmonary HypertensionRandomizedSickle Cell AnemiaSildenafilWalking
Grant awards (3)
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension$106,487
N01 · FY2011 · HL · contact PI
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension$115,356
N01 · FY2010 · HL · contact PI
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension$134,219
N01 · FY2009 · HL · contact PI